Logo image
Specific clinical phenotypes in relapsing multiple sclerosis: The impact of relapses on long-term outcomes
Journal article

Specific clinical phenotypes in relapsing multiple sclerosis: The impact of relapses on long-term outcomes

Thomas F Scott, Edward J Gettings, Christopher T Hackett and Carol J Schramke
Multiple sclerosis and related disorders, v 5
Jan 2016
PMID: 26856936

Abstract

Adult Cohort Studies Disease Progression Female Humans Male Multiple Sclerosis, Relapsing-Remitting - diagnosis Phenotype
The impact of relapses on the disease course of relapsing MS remains to be determined. This study aims to identify and characterize clinical phenotypes of relapse onset MS in a longitudinally studied cohort. We recorded the clinical course of MS during the first decade of disease, using five-year epochs. Patients were stratified as: no worsening due to relapse or secondary progression (type A), relapse with worsening seen without secondary progression (type B), secondary progression with no worsening due to relapse (type C), worsening due to relapses mixed with secondary progression (type D). Of 176 patients followed from diagnosis for 12.62 ± 4.18 years, 93.2% (164/176) had increased disability in their first 5-year epoch of MS and 52.2% (72/138) in the next. The phenotypes significantly differed by EDSS change during each epoch (p<0.001), final confirmed MSSS (p ≤ 0.002) and relapse rate (p<0.001). Type D fared worse than others by change in EDSS and MSSS. We identified multiple specific phenotypes of MS and temporal shifts between phenotypes according to relapse type and progression.

Metrics

7 Record Views
7 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Clinical Neurology
Logo image